Catalent Pharma Solutions Appoints New Packaging Services Segment President
Somerset, NJ, May 3, 2010 — Catalent Pharma Solutions, Inc. announced today the appointment of Barry D. Russell as Group President, Commercial Packaging, effective May 1, 2010. Mr. Russell will have full responsibility for Catalent’s Packaging Services segment, including leading more than 2,200 employees at nine pharmaceutical packaging and printing facilities in both North America and Europe. Mr. Russell will report to John Chiminski, President and CEO of Catalent, and will be based in Catalent’s flagship Philadelphia packaging facility. David Heyens, the current incumbent, will simultaneously step down from the role.
Mr. Russell comes to Catalent with more than twenty-five years of leadership, operational, marketing, and engineering experience. He most recently served as an operating Vice President for Ferro Corporation, where he had full responsibility for the global Electronic Materials Systems business. Before that, Mr. Russell spent six years at Honeywell International, in a variety of leadership and marketing roles. Mr. Russell also held prior leadership, marketing, operational, and engineering positions with Matson-CFM Technologies, Inc., FMC Corporation, and Eveready Battery Corporation. Mr. Russell holds a B.S. in chemical engineering from the University of Akron (Ohio), and a Masters in Business Administration from the University of North Carolina.
John Chiminski, Catalent’s President and CEO, said, “We are pleased to have Barry join the Catalent executive team. He brings experience and proven expertise in driving both operational and commercial excellence, which precisely aligns with Catalent’s approach.” Mr. Chiminski continued, “I also want to thank Dave for his many contributions during his fifteen years of outstanding service. We will benefit from and build upon his legacy.”
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit www.catalent.com .